{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:11:03Z","timestamp":1788210663534,"version":"build-2803163510"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaoncol.2020.2922","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:32:03Z","timestamp":1596141123000},"page":"1381","source":"Crossref","is-referenced-by-count":52,"title":["Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk"],"prefix":"10.1001","volume":"6","author":[{"given":"H. Amarens","family":"Geuzinge","sequence":"first","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge-Marie","family":"Obdeijn","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel J. T.","family":"Rutgers","sequence":"additional","affiliation":[{"name":"Department of Surgery, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Saadatmand","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritse M.","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Radboud University Hospital, Nijmegen, the Netherlands"},{"name":"Department of Radiology and Nuclear Medicine, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical Centre Leeuwarden, Leeuwarden, the Netherlands"},{"name":"Department of Genetics, Groningen University, University Medical Centre Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob A. E. M.","family":"Tollenaar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diderick B. W.","family":"de Roy van Zuidewijn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical Centre Leeuwarden, Leeuwarden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B. I.","family":"Lobbes","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijne","family":"van \u2018t Riet","sequence":"additional","affiliation":[{"name":"Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje J.","family":"Hooning","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet G. E. M.","family":"Ausems","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudette E.","family":"Loo","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[{"name":"Department of Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest J. T.","family":"Luiten","sequence":"additional","affiliation":[{"name":"Department of Surgery, Amphia Ziekenhuis, Breda, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmien M.","family":"Zonderland","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Verhoef","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline A. M.","family":"Heijnsdijk","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine M. A.","family":"Tilanus-Linthorst","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"de Koning","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Familial MRI Screening (FaMRIsc) Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"coi200039r1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/oxfordjournals.aje.a115616","article-title":"Age at onset as an indicator of familial risk of breast cancer.","volume":"131","author":"Claus","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"5","key":"coi200039r2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer.","volume":"374","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"key":"coi200039r3","doi-asserted-by":"crossref","first-page":"h4901","DOI":"10.1136\/bmj.h4901","article-title":"Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients.","volume":"351","author":"Saadatmand","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"coi200039r4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"coi200039r7","doi-asserted-by":"crossref","first-page":"W292","DOI":"10.2214\/AJR.10.6049","article-title":"The relationship of mammographic density and age: implications for breast cancer screening.","volume":"198","author":"Checka","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"coi200039r8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer.","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"coi200039r9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","article-title":"MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.","volume":"20","author":"Saadatmand","year":"2019","journal-title":"Lancet Oncol"},{"issue":"13","key":"coi200039r10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.2012.388","article-title":"Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.","volume":"307","author":"Berg","year":"2012","journal-title":"JAMA"},{"issue":"17","key":"coi200039r11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djt203","article-title":"Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.","volume":"105","author":"Saadatmand","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"coi200039r12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/1471-2407-12-440","article-title":"Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.","volume":"12","author":"Saadatmand","year":"2012","journal-title":"BMC Cancer"},{"issue":"20","key":"coi200039r13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"coi200039r14","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.29572","article-title":"Cost-effectiveness of digital mammography screening before the age of 50 in the Netherlands.","volume":"137","author":"Sankatsing","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"coi200039r15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","article-title":"Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations.","volume":"225","author":"Kolb","year":"2002","journal-title":"Radiology"},{"issue":"1","key":"coi200039r16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-014-3074-8","article-title":"The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review.","volume":"147","author":"Roeke","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"coi200039r17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1287\/mnsc.42.7.954","article-title":"Nelder-Mead simplex modifications for simulation optimization.","volume":"42","author":"Barton","year":"1996","journal-title":"Manag Sci."},{"issue":"7","key":"coi200039r21","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.socscimed.2006.04.018","article-title":"Health care costs in the last year of life\u2014the Dutch experience.","volume":"63","author":"Polder","year":"2006","journal-title":"Soc Sci Med"},{"issue":"4","key":"coi200039r22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D.","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"issue":"11","key":"coi200039r23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jnci\/djj210","article-title":"Retrospective cost-effectiveness analysis of screening mammography.","volume":"98","author":"Stout","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi200039r24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910490411","article-title":"The impact of a breast cancer screening programme on quality-adjusted life-years.","volume":"49","author":"de Haes","year":"1991","journal-title":"Int J Cancer"},{"issue":"1","key":"coi200039r25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bjc.6601912","article-title":"Impact of screening for breast cancer in high-risk women on health-related quality of life.","volume":"91","author":"Rijnsburger","year":"2004","journal-title":"Br J Cancer"},{"issue":"6","key":"coi200039r27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11136-007-9202-8","article-title":"Health related quality of life in different states of breast cancer.","volume":"16","author":"Lidgren","year":"2007","journal-title":"Qual Life Res"},{"issue":"2","key":"coi200039r28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1667\/0033-7587(2002)158[0220:REOBCR]2.0.CO;2","article-title":"Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.","volume":"158","author":"Preston","year":"2002","journal-title":"Radiat Res"},{"issue":"7","key":"coi200039r29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/bjc.2011.67","article-title":"Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.","volume":"104","author":"de Gelder","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"coi200039r31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ijc.28014","article-title":"Optimal age to start preventive measures in women with BRCA1\/2 mutations or high familial breast cancer risk.","volume":"133","author":"Tilanus-Linthorst","year":"2013","journal-title":"Int J Cancer"},{"issue":"22","key":"coi200039r32","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue.","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"key":"coi200039r33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.socscimed.2019.03.028","article-title":"Valuing the health states associated with breast cancer screening programmes: a systematic review of economic measures.","volume":"228","author":"Bromley","year":"2019","journal-title":"Soc Sci Med"},{"issue":"5","key":"coi200039r34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/erp.10.65","article-title":"Health-state utility values in breast cancer.","volume":"10","author":"Peasgood","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"coi200039r35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hec.3041","article-title":"Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers.","volume":"24","author":"Stollenwerk","year":"2015","journal-title":"Health Econ"},{"issue":"22","key":"coi200039r36","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1200\/JCO.2013.52.5386","article-title":"Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection\u2014a novel approach to breast cancer screening with MRI.","volume":"32","author":"Kuhl","year":"2014","journal-title":"J Clin Oncol"},{"key":"coi200039r6","volume-title":"American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas).","author":"American College of Radiology","year":"2003"},{"key":"coi200039r20","volume-title":"Referentieprijzen Voor Economische Evaluaties in de Gezondheidszorg.","author":"Hakkaart-van Roijen","year":"2015"},{"key":"coi200039r26","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"coi200039r5","unstructured":"oncoline. Richtlijn mammacarcinoom (breast cancer national guideline). Accessed January 15, 2019.https:\/\/www.oncoline.nl\/borstkanker."},{"key":"coi200039r18","unstructured":"CZ Healthcare Insurance. Tarieventool. Accessed October 3, 2018. https:\/\/www.cz.nl\/service-en-contact\/zoek-tarieven?"},{"key":"coi200039r19","unstructured":"Netherlands Comprehensive Cancer Organisation (IKNL). Monitor bevolkingsonderzoek borstkanker 2016. Published June 2018. Accessed July 9, 2019. https:\/\/www.rivm.nl\/sites\/default\/files\/2018-11\/Monitor%20bevolkingsonderzoek%20borstkanker%202016%20webversie.pdf?"},{"key":"coi200039r30","unstructured":"National Institute for Health and Care Excellence. Guide to the processes of technology appraisal. Published April 2019. Accessed June 25, 2020. https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-technology-appraisals\/technology-appraisal-processes-guide-apr-2018.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2768633\/jamaoncology_geuzinge_2020_oi_200039_1599155158.54212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T02:41:31Z","timestamp":1723344091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2768633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.2922","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}